Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Independence Blue Cross | Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) DevicesPayerPolicy · IBX-COMMERCIAL-07-02-09 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Alpha-1 Antitrypsin Therapy (e.g., Prolastin-C, Aralast NP, Glassia, Zemaira)PayerPolicy · IBX-COMMERCIAL-08-00-91 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | AlloMap Molecular Expression Testing for Heart Transplant Rejection (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-06-02-29 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Allogeneic Processed Thymus Tissue-agdc (Rethymic)PayerPolicy · IBX-COMMERCIAL-08-01-88 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Allergy ImmunotherapyPayerPolicy · IBX-COMMERCIAL-07-00-21 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Alglucosidase alfa (e.g., Lumizyme), Avalglucosidase alfa-ngpt (Nexviazyme ), Cipaglucosidase alfa-atga (Pombiliti )PayerPolicy · IBX-COMMERCIAL-08-00-72 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Alemtuzumab (Lemtrada)PayerPolicy · IBX-COMMERCIAL-08-01-22 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Air Ambulance ServicesPayerPolicy · IBX-COMMERCIAL-12-04-03 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Agalsidase beta (Fabrazyme) and pegunigalsidase alfa-iwxj (Elfabrio)PayerPolicy · IBX-COMMERCIAL-08-00-69 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Afamitresgene autoleucel (Tecelra)PayerPolicy · IBX-COMMERCIAL-08-02-32 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Ado-Trastuzumab Emtansine (Kadcyla)PayerPolicy · IBX-COMMERCIAL-08-01-11 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | ADAMTS13, recombinant-krhn (Adzynma)PayerPolicy · IBX-COMMERCIAL-08-02-21 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Acute Care Facility Inpatient TransfersPayerPolicy · IBX-COMMERCIAL-12-04-04 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | AcupuncturePayerPolicy · IBX-COMMERCIAL-12-00-01 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Ablation of Lung TumorsPayerPolicy · IBX-COMMERCIAL-11-00-16 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Abatacept (Orencia) for Injection for Intravenous UsePayerPolicy · IBX-COMMERCIAL-08-00-62 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Low-Level Laser TherapyPayerPolicy · IBX-COMMERCIAL-07-00-14 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Pompe Disease Treatment with Lumizyme (Alglucosidase alfa)PayerPolicy · BCBSNJ-DRUGS-044-434BE64CB4 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Closure Devices for Patent Foramen Ovale and Atrial Septal DefectsPayerPolicy · BCBSNJ-SURGERY-066-342C7ED11B | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Injectable Bulking Agents for the Treatment of Urinary IncontinencePayerPolicy · BCBSNJ-SURGERY-037-C74AA2BCDA | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Cooling Devices Used in the Outpatient SettingPayerPolicy · BCBSNJ-D-M-E-004-E1438BAD8B | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Opioid Antagonists Under Heavy Sedation or General Anesthesia as a Technique of Opioid DetoxificationPayerPolicy · BCBSNJ-TREATMENT-011-9E7D63215E | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Transcatheter Arterial Chemoembolization To Treat Primary or Metastatic Liver MalignanciesPayerPolicy · BCBSNJ-SURGERY-034-75C2D1ECE9 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Percutaneous Vertebroplasty and SacroplastyPayerPolicy · BCBSNJ-TREATMENT-029-140F3D0F1C | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Photodynamic Therapy for Choroidal NeovascularizationPayerPolicy · BCBSNJ-TREATMENT-027-333AF5958E | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Granulocyte Colony Stimulating Factor (G-CSF - Neupogen, Neulasta, Granix, Zarxio, Fulphila, Nivestym, Udenyca, Ziextenzo, Nyvepria) and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF - Leukine)PayerPolicy · BCBSNJ-DRUGS-012-E7C32F18C6 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Decompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency Coblation (Nucleoplasty)PayerPolicy · BCBSNJ-TREATMENT-077-641E233965 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Trastuzumab (Herceptin), Trastuzumab-dkst (Ogivri), Ado-trastuzumab emtansine (Kadcyla), Trastuzumab-pkrb (Herzuma), Trastuzumab-dttb (Ontruzant), Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta), Trastuzumab-qyyp (Trazimera), Trastuzumab-anns (Kanjinti), Fam-trastuzumab deruxtecan-nxki (Enhertu), Pertuzumab (Perjeta), and Pertuzumab, Trastuzumab, and hyaluronidase-zzxf (Phesgo)PayerPolicy · BCBSNJ-DRUGS-011-749DD9CCDF | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Topotecan Hydrochloride (Hycamtin) InjectionPayerPolicy · BCBSNJ-DRUGS-020-CF390C2BC8 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Dynamic PosturographyPayerPolicy · BCBSNJ-MEDICINE-015-32E82A227C | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Bone Mineral Density Studies and Vertebral Fracture Assessment With DensitometryPayerPolicy · BCBSNJ-RADIOLOGY-005-B60AEABC47 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Reduction MammaplastyPayerPolicy · BCBSNJ-SURGERY-028-113D8EFE84 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | SeptoplastyPayerPolicy · BCBSNJ-SURGERY-031-D65AAFB2B6 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Tumor Markers Other Than Prostate Specific Antigen (PSA)PayerPolicy · BCBSNJ-PATHOLOGY-001-AF0843E870 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Quantitative Sensory TestingPayerPolicy · BCBSNJ-MEDICINE-031-7DA387DE13 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Transmyocardial RevascularizationPayerPolicy · BCBSNJ-SURGERY-009-22D1AEDABE | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Definition of Medical NecessityPayerPolicy · BCBSNJ-INTRODUCTION-003-534F08DAED | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Continuous Passive Motion DevicePayerPolicy · BCBSNJ-D-M-E-017-B08B36FD59 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Percutaneous Intradiscal Electrothermal Annuloplasty, Radiofrequency Annuloplasty, and BiacuplastyPayerPolicy · BCBSNJ-TREATMENT-023-92B147EA31 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Colon HydrotherapyPayerPolicy · BCBSNJ-TREATMENT-071-C96D31B2BE | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Whole-Body CT ScreeningPayerPolicy · BCBSNJ-RADIOLOGY-019-55022F6424 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Transplant Donor and Recipient PolicyPayerPolicy · BCBSNJ-SURGERY-003-598BDAB21B | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Intravenous/Intramuscular Vitamin and/or Mineral TherapyPayerPolicy · BCBSNJ-TREATMENT-072-85519820DD | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Neuromuscular Electrical Stimulation (NMES) and Functional Electrical Stimulation (FES)PayerPolicy · BCBSNJ-D-M-E-014-1FC6B194B5 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Progesterone Therapy as a Technique to Reduce Preterm Delivery in High Risk PregnanciesPayerPolicy · BCBSNJ-OBSTETRICS-006-F86C46D1F6 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Enhanced External Counterpulsation (EECP)PayerPolicy · BCBSNJ-TREATMENT-014-01D0727392 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Medical Nutritional Therapy for Inherited Metabolic DiseasePayerPolicy · BCBSNJ-TREATMENT-018-5E1DC4DA82 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Wireless Capsule Endoscopy as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus, and ColonPayerPolicy · BCBSNJ-RADIOLOGY-017-B004635ADF | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Abdominoplasty, Panniculectomy and Diastasis Muscle RepairPayerPolicy · BCBSNJ-SURGERY-025-0211F636D2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Dermatologic Applications of Photodynamic TherapyPayerPolicy · BCBSNJ-TREATMENT-064-6754F99925 | New policy |
|---|